Skip to main content
main-content

06.08.2018 | Original Article

Diagnostic Prevalence of Common Psychiatric Comorbidities of Alcohol Use Disorders in India: a Systematic Review

Zeitschrift:
International Journal of Mental Health and Addiction
Autoren:
Rebecca Hendrickson, J. H. Nishanth, Scott Michael
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s11469-018-9951-3) contains supplementary material, which is available to authorized users.

Abstract

The diagnostic prevalence of mood and anxiety disorders in Indian individuals with alcohol use disorders (AUDs) has important implications for clinical decision making and for cross-cultural psychiatry research. Here, we present a systematic review of comorbid mood and anxiety disorders in Indian patients with AUDs. We find rates of comorbid mood disorders ranging from 6 to 65% (estimated overall effect from a linear random effects model of 18.0%, 95% CI [5.6, 45.1]) and rates of comorbid anxiety disorders ranging from 0 to 30% (estimated overall effect of 2.4%, 95% CI [0.9, 5.8]) in Indian populations. These findings are placed in the context of estimated population prevalence of comorbid mood and anxiety disorders in US adults with AUDs who have recently sought treatment of 40.7 (95% CI [32.6, 48.7]) and 33.4% (95% CI [25.2, 41.6]), respectively. Potential causes of these differences include differences in diagnosis, in cultural norms around alcohol use and the acceptance of mental health care, and in the types of studies being compared. The findings highlight the importance of systematic assessments of treatment outcomes in local clinical populations as a complement to an understanding of the medical literature from other cultural contexts.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Nicht verpassen: e.Med bis 22. Oktober 100 € günstiger.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
Literatur
Über diesen Artikel
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.